668 related articles for article (PubMed ID: 25641255)
1. Prognostic utility of myocardial blush grade after PCI in patients with NSTE-ACS: Analysis from the ACUITY trial.
Ng VG; Lansky AJ; Toro S; Parise H; Cristea E; Mehran R; Stone GW
Catheter Cardiovasc Interv; 2016 Aug; 88(2):215-24. PubMed ID: 25641255
[TBL] [Abstract][Full Text] [Related]
2. Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).
Lansky AJ; Ng VG; Meller S; Xu K; Fahy M; Feit F; Ohman EM; White HD; Mehran R; Bertrand ME; Desmet W; Hamon M; Stone GW
JACC Cardiovasc Interv; 2014 Mar; 7(3):266-75. PubMed ID: 24650400
[TBL] [Abstract][Full Text] [Related]
3. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
Pride YB; Mohanavelu S; Zorkun C; Kunadian V; Giugliano RP; Newby LK; Braunwald E; Califf RM; Harrington RA; Gibson CM;
JACC Cardiovasc Interv; 2012 Sep; 5(9):927-35. PubMed ID: 22995880
[TBL] [Abstract][Full Text] [Related]
4. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
[TBL] [Abstract][Full Text] [Related]
5. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
[TBL] [Abstract][Full Text] [Related]
7. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
Porto I; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimský P; Le Gall N; Zagar AJ; LeNarz LA; Miller D; Montalescot G;
JACC Cardiovasc Interv; 2016 May; 9(9):897-907. PubMed ID: 27151605
[TBL] [Abstract][Full Text] [Related]
8. Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction.
Brener SJ; Cristea E; Lansky AJ; Fahy M; Mehran R; Stone GW
Circ Cardiovasc Interv; 2012 Aug; 5(4):563-9. PubMed ID: 22828707
[TBL] [Abstract][Full Text] [Related]
9. Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome.
Nammas W; Pietilä M; Romppanen H; Sia J; DeBelder A; Karjalainen PP
Scand Cardiovasc J; 2017 Oct; 51(5):248-254. PubMed ID: 28666394
[TBL] [Abstract][Full Text] [Related]
10. Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.
Rakowski T; Dudek D; Dziewierz A; Yu J; Witzenbichler B; Guagliumi G; Kornowski R; Hartmann F; Lansky AJ; Brener SJ; Mehran R; Stone GW
EuroIntervention; 2013 Mar; 8(11):1307-14. PubMed ID: 23538158
[TBL] [Abstract][Full Text] [Related]
11. Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).
Prasad A; Gersh BJ; Mehran R; Brodie BR; Brener SJ; Dizon JM; Lansky AJ; Witzenbichler B; Kornowski R; Guagliumi G; Dudek D; Stone GW
JACC Cardiovasc Interv; 2015 Dec; 8(15):1966-1974. PubMed ID: 26738667
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.
Stepinska J; Wojtkowska I; Annemans L; Danchin N; Pocock SJ; de Werf FV; Medina J; Bueno H
Curr Vasc Pharmacol; 2020; 18(1):92-99. PubMed ID: 30588886
[TBL] [Abstract][Full Text] [Related]
13. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
Murai T; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Hamaya R; Kanno Y; Lee T; Kakuta T
Catheter Cardiovasc Interv; 2018 Nov; 92(6):1063-1074. PubMed ID: 29446567
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes.
Kasula S; Agarwal SK; Hacioglu Y; Pothineni NK; Bhatti S; Ahmed Z; Uretsky B; Hakeem A
Heart; 2016 Dec; 102(24):1988-1994. PubMed ID: 27492942
[TBL] [Abstract][Full Text] [Related]
16. Angiographic characteristics of definite stent thrombosis: role of thrombus grade, collaterals, epicardial coronary flow, and myocardial perfusion.
Reeves RR; Patel M; Armstrong EJ; Sab S; Waldo SW; Yeo KK; Shunk KA; Low RI; Rogers JH; Mahmud E
Catheter Cardiovasc Interv; 2015 Jan; 85(1):13-22. PubMed ID: 24753053
[TBL] [Abstract][Full Text] [Related]
17. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
[TBL] [Abstract][Full Text] [Related]
18. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
[TBL] [Abstract][Full Text] [Related]
19. Tissue characteristics of culprit lesion and myocardial tissue-level perfusion in non-ST-segment elevation acute coronary syndromes: The EARLY-MYO-ACS study.
Yang G; Wang W; Sheng X; Yang F; Kong L; He J; Ding S; Shan P; Shang Y; Xiu J; Yang Y; Mintz GS; Pu J
Int J Cardiol; 2019 Jul; 287():32-38. PubMed ID: 30772013
[TBL] [Abstract][Full Text] [Related]
20. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy.
Yadav M; Généreux P; Palmerini T; Caixeta A; Madhavan MV; Xu K; Brener SJ; Mehran R; Stone GW
Catheter Cardiovasc Interv; 2015 Jan; 85(1):1-10. PubMed ID: 24408084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
